LNSR Q3 2023 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$142M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$10M+26.4% YoY

Gross Profit

$5M49.8% margin

Operating Income

-$2M-20.8% margin

Net Income

$3M26.2% margin

EPS (Diluted)

$0.21

QoQ Revenue Growth

-18.5%

Cash Flow

Operating Cash Flow

-$339,000

Free Cash Flow

-$341,000

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$71M

Total Liabilities

$34M

Stockholders' Equity

$36M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$8M	+26.4%
Gross Profit	$5M	$4M	+25.4%
Operating Income	-$2M	-$4M	+50.0%
Net Income	$3M	-$4M	+164.3%

Revenue Segments

Product

$7M87%

Service

$1M13%

Geographic Segments

UNITED STATES

$6M69%

Asia Excluding South Korea

$1M13%

Europe

$934,00011%

Other Geographical Region

$481,0006%

KOREA, REPUBLIC OF

$9,0000%